2023 Q3 Form 10-Q Financial Statement

#000138865823000105 Filed on August 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $124.6M $124.1M $102.1M
YoY Change 19.96% 21.64% 25.56%
Cost Of Revenue $42.13M $37.91M $31.81M
YoY Change 27.84% 19.18% 22.35%
Gross Profit $82.47M $86.23M $70.25M
YoY Change 16.29% 22.75% 27.06%
Gross Profit Margin 66.19% 69.46% 68.83%
Selling, General & Admin $93.77M $91.42M $81.75M
YoY Change 16.4% 11.83% 30.45%
% of Gross Profit 113.69% 106.02% 116.38%
Research & Development $16.31M $13.68M $11.95M
YoY Change 42.46% 14.5% 24.35%
% of Gross Profit 19.77% 15.86% 17.0%
Depreciation & Amortization $4.100M $3.800M $3.351M
YoY Change 19.32% 13.4% 55.93%
% of Gross Profit 4.97% 4.41% 4.77%
Operating Expenses $110.1M $105.1M $93.70M
YoY Change 19.64% 12.17% 29.64%
Operating Profit -$27.60M -$18.87M -$23.45M
YoY Change 30.91% -19.53% 38.01%
Interest Expense $927.0K $832.0K $482.0K
YoY Change -250.98% 72.61% 57.0%
% of Operating Profit
Other Income/Expense, Net $1.600M $1.435M $69.00K
YoY Change 338.36% 1979.71% 25.45%
Pretax Income -$26.92M -$18.27M -$23.86M
YoY Change 26.18% -23.45% 38.39%
Income Tax $195.0K $213.0K $33.00K
% Of Pretax Income
Net Earnings -$27.12M -$18.48M -$23.90M
YoY Change 26.41% -22.66% 37.66%
Net Earnings / Revenue -21.76% -14.89% -23.42%
Basic Earnings Per Share -$0.89 -$0.61 -$0.80
Diluted Earnings Per Share -$0.89 -$0.61 -$0.80
COMMON SHARES
Basic Shares Outstanding 30.58M shares 30.47M shares 29.84M shares
Diluted Shares Outstanding 30.61M shares 30.50M shares 29.84M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $158.5M $164.7M $204.5M
YoY Change -22.14% -19.44% -20.02%
Cash & Equivalents $47.48M $61.58M $101.3M
Short-Term Investments $111.0M $103.2M $103.2M
Other Short-Term Assets $12.10M $11.82M $8.526M
YoY Change 65.17% 38.59% 18.11%
Inventory $13.65M $14.48M $14.42M
Prepaid Expenses
Receivables $50.07M $51.11M $57.38M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $234.3M $242.1M $284.8M
YoY Change -18.04% -14.98% -15.12%
LONG-TERM ASSETS
Property, Plant & Equipment $96.67M $89.85M $65.92M
YoY Change -27.6% 36.29% 40.01%
Goodwill $862.0K $862.0K $862.0K
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $47.05M $38.72M $20.14M
YoY Change 133.45% 92.25% 42.09%
Total Long-Term Assets $205.5M $187.3M $150.9M
YoY Change 32.96% 24.18% 0.81%
TOTAL ASSETS
Total Short-Term Assets $234.3M $242.1M $284.8M
Total Long-Term Assets $205.5M $187.3M $150.9M
Total Assets $439.8M $429.5M $435.7M
YoY Change -0.14% -1.42% -10.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.212M $7.150M $5.987M
YoY Change -2.59% 19.43% -33.07%
Accrued Expenses $76.63M $64.47M $49.95M
YoY Change 4.71% 29.06% 17.27%
Deferred Revenue $3.400M $3.695M $2.977M
YoY Change 13.22% 24.12% 18.75%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $102.3M $89.41M $70.42M
YoY Change 22.37% 26.98% -3.56%
LONG-TERM LIABILITIES
Long-Term Debt $34.95M $34.94M $34.93M
YoY Change 0.04% 0.04% 125.12%
Other Long-Term Liabilities $1.013M $1.012M $952.0K
YoY Change -98.77% 6.3% -57.97%
Total Long-Term Liabilities $35.96M $35.95M $35.88M
YoY Change -69.42% 0.21% 101.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $102.3M $89.41M $70.42M
Total Long-Term Liabilities $35.96M $35.95M $35.88M
Total Liabilities $220.0M $205.6M $191.0M
YoY Change 9.35% 7.62% 6.86%
SHAREHOLDERS EQUITY
Retained Earnings -$606.9M -$579.8M -$480.6M
YoY Change 20.9% 20.65% 37.37%
Common Stock $826.7M $803.8M $725.8M
YoY Change 11.43% 10.75% 10.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $219.8M $223.9M $244.6M
YoY Change
Total Liabilities & Shareholders Equity $439.8M $429.5M $435.7M
YoY Change -0.14% -1.42% -10.21%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$27.12M -$18.48M -$23.90M
YoY Change 26.41% -22.66% 37.66%
Depreciation, Depletion And Amortization $4.100M $3.800M $3.351M
YoY Change 19.32% 13.4% 55.93%
Cash From Operating Activities $1.200M -$4.572M -$372.0K
YoY Change -67.29% 1129.03% -31.74%
INVESTING ACTIVITIES
Capital Expenditures $9.090M $9.397M -$10.83M
YoY Change -243.53% -186.75% 82.85%
Acquisitions
YoY Change
Other Investing Activities -$6.350M $18.41M $10.40M
YoY Change -78.13% 76.96% 36.48%
Cash From Investing Activities -$15.44M $9.009M -$431.0K
YoY Change -56.34% -2190.26% -125.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 60.00K 4.381M 7.270M
YoY Change -96.39% -39.74% 2025.73%
NET CHANGE
Cash From Operating Activities 1.200M -4.572M -372.0K
Cash From Investing Activities -15.44M 9.009M -431.0K
Cash From Financing Activities 60.00K 4.381M 7.270M
Net Change In Cash -14.18M 8.818M 6.467M
YoY Change -52.78% 36.35% 332.86%
FREE CASH FLOW
Cash From Operating Activities $1.200M -$4.572M -$372.0K
Capital Expenditures $9.090M $9.397M -$10.83M
Free Cash Flow -$7.890M -$13.97M $10.46M
YoY Change -178.88% -233.55% 94.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30577519 shares
dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.001 Per Share
dei Trading Symbol
TradingSymbol
IRTC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30550000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30550000 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.80
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.80
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29843000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29843000 shares
us-gaap Other Noncash Expense
OtherNoncashExpense
141000 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
227000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
239812000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
905000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19899000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-39109000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
327000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
221834000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-44000 usd
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, contractual allowances, allowance for doubtful accounts, the useful lives of property and equipment, the recoverability of long-lived assets including the estimated usage of the printed circuit board assemblies (“PCBAs”), the incremental borrowing rate for operating leases, accounting for income taxes, impairment of ROU assets, and various inputs used in estimating stock-based compensation. Actual results may differ from those estimates.</span></div>
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
18475000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
14012000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
14012000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
9424000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
17191000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7623000 usd
irtc Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments
AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments
8489000 usd
CY2022 irtc Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments
AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments
12728000 usd
irtc Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments
AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments
7000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
19410000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
18475000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
21628000 usd
CY2022Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
41389000 usd
CY2021Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
31274000 usd
CY2021Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
31274000 usd
irtc Accounts Receivable Allowance For Contractual Adjustments
AccountsReceivableAllowanceForContractualAdjustments
28062000 usd
CY2022 irtc Accounts Receivable Allowance For Contractual Adjustments
AccountsReceivableAllowanceForContractualAdjustments
41158000 usd
irtc Accounts Receivable Allowance For Contractual Adjustments
AccountsReceivableAllowanceForContractualAdjustments
21626000 usd
irtc Accounts Receivable Contractual Adjustments
AccountsReceivableContractualAdjustments
21537000 usd
CY2022 irtc Accounts Receivable Contractual Adjustments
AccountsReceivableContractualAdjustments
31043000 usd
irtc Accounts Receivable Contractual Adjustments
AccountsReceivableContractualAdjustments
38000 usd
CY2023Q2 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
47914000 usd
CY2022Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
41389000 usd
CY2022Q2 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
52862000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Risk</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents, investments and accounts receivable. Cash balances are deposited in financial institutions which, at times, may be in excess of federally insured limits. Cash equivalents are invested in highly rated money market funds. The Company invests in a variety of financial instruments, such as, but not limited to, U.S. government securities, corporate notes, commercial paper and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. The Company has not experienced any material losses on its deposits of cash and cash equivalents or investments.</span></div>Concentrations of credit risk with respect to accounts receivable are limited due to the large number of customers comprising the Company’s customer base and their dispersion across many geographies. The Company does not require collateral. The Company records an allowance for doubtful accounts based on the assessment of the collectability of customer accounts, considering factors such as historical experience, credit quality, the age of the accounts receivable balances, and current economic conditions that may affect a customer’s ability to pay.
CY2023Q2 irtc Number Of Zio System Options
NumberOfZioSystemOptions
3 systemoption
CY2023Q2 irtc Number Of Performance Obligations
NumberOfPerformanceObligations
2 performanceobligation
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
3000000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3000000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3000000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
131779000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
113000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
131670000 usd
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
28509000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
103161000 usd
CY2023Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
131670000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
158972000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
12000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
409000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
158575000 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
24263000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
134312000 usd
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
158575000 usd
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
131670000 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
158575000 usd
CY2023Q2 us-gaap Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
7208000 usd
CY2022Q4 us-gaap Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
9338000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7270000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5817000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
14478000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
15155000 usd
CY2023Q2 irtc Printed Circuit Board Assemblies
PrintedCircuitBoardAssemblies
30153000 usd
CY2022Q4 irtc Printed Circuit Board Assemblies
PrintedCircuitBoardAssemblies
18599000 usd
CY2023Q2 irtc Cloud Computing Arrangements
CloudComputingArrangements
4443000 usd
CY2022Q4 irtc Cloud Computing Arrangements
CloudComputingArrangements
2523000 usd
CY2023Q2 irtc Strategic Investment
StrategicInvestment
3000000 usd
CY2022Q4 irtc Strategic Investment
StrategicInvestment
0 usd
CY2023Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1127000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1130000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38723000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22252000 usd
irtc Assets Purchase Accounting Adjustments
AssetsPurchaseAccountingAdjustments
11600000 usd
CY2023Q2 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
132156000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
110886000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42311000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35216000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
89845000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75670000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3800000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7400000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3400000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6500000 usd
CY2023Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2800000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
5500000 usd
CY2022Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2500000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
4700000 usd
CY2023Q2 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
8900000 usd
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
16800000 usd
CY2023Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
27159000 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
34752000 usd
CY2023Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
10041000 usd
CY2022Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
8608000 usd
CY2023Q2 irtc Accrued Expenses Current
AccruedExpensesCurrent
10255000 usd
CY2022Q4 irtc Accrued Expenses Current
AccruedExpensesCurrent
7006000 usd
CY2023Q2 irtc Claims Payable Current
ClaimsPayableCurrent
7257000 usd
CY2022Q4 irtc Claims Payable Current
ClaimsPayableCurrent
4464000 usd
CY2023Q2 irtc Accrued Employee Stock Purchase Plan Contribution
AccruedEmployeeStockPurchasePlanContribution
1090000 usd
CY2022Q4 irtc Accrued Employee Stock Purchase Plan Contribution
AccruedEmployeeStockPurchasePlanContribution
1045000 usd
CY2023Q2 irtc Accrued State Local And Foreign Taxes
AccruedStateLocalAndForeignTaxes
2604000 usd
CY2022Q4 irtc Accrued State Local And Foreign Taxes
AccruedStateLocalAndForeignTaxes
2388000 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6063000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
7234000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
64469000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
65497000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
3100000 usd
us-gaap Professional Fees
ProfessionalFees
800000 usd
CY2022Q1 irtc Reduction To Leased Square Footage Percent
ReductionToLeasedSquareFootagePercent
0.50
us-gaap Asset Impairment Charges
AssetImpairmentCharges
23200000 usd
us-gaap Restructuring Charges
RestructuringCharges
3444000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
23164000 usd
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
26608000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
10417000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
20592000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
20385000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
20136000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
19736000 usd
CY2023Q2 irtc Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
36124000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
127390000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
33049000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
94341000 usd
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1800000 usd
CY2023Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
8400000 usd
CY2023Q2 irtc Operating Loss Carryforwards Tax Benefit Recognized
OperatingLossCarryforwardsTaxBenefitRecognized
0 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Dividends Common Stock
DividendsCommonStock
0 usd
CY2023Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9865000 shares
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
10177000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
328000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
43.00
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y5M4D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
16635000 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
19000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
54.14
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
309000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
42.31
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M28D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
19161000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
309000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
42.31
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y10M28D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
19161000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14099000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15098000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32350000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29001000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-18482000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-23897000 usd
us-gaap Net Income Loss
NetIncomeLoss
-57591000 usd
us-gaap Net Income Loss
NetIncomeLoss
-74506000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30502000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30502000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29843000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29843000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30400000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29720000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.80
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.80
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.51
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2827000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2398000 shares
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001388658-23-000105-index-headers.html Edgar Link pending
0001388658-23-000105-index.html Edgar Link pending
0001388658-23-000105.txt Edgar Link pending
0001388658-23-000105-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
irtc-20230630.htm Edgar Link pending
irtc-20230630.xsd Edgar Link pending
irtc-20230630xex311.htm Edgar Link pending
irtc-20230630xex312.htm Edgar Link pending
irtc-20230630xex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
irtc-20230630_cal.xml Edgar Link unprocessable
irtc-20230630_def.xml Edgar Link unprocessable
irtc-20230630_lab.xml Edgar Link unprocessable
irtc-20230630_pre.xml Edgar Link unprocessable
irtc-20230630_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending